Biotech Startups

Cimico develops biotechnology solutions for municipal and industrial wastewater treatment, centered on its energy-efficient MBBR (MOBED) technology and the Helinia digital platform for monitoring, advanced control, and digital twin. It also offers the FILMATH mathematical simulation tool and serves sectors such as food processing, textiles/laundries, refineries, and small seasonal municipalities.

1 investor

CIMPLRX discovers and develops drug candidates using its own explainable AI platform, CEEK-CURE, which builds machine learning models for target- and compound-based hit identification, lead optimization, and mechanism-of-action analysis. It serves biotech and pharmaceutical companies with tools to design new compounds, screen chemical libraries, and visualize the drug discovery process.

1 investor

CinderBio develops HTA-Proteases, specialized enzymes for proteomics research that enable comprehensive protein analysis through orthogonal digestion approaches. The company serves life sciences and biotech researchers requiring advanced tools for protein characterization and mass spectrometry applications.

1 investor

CINV is a pharmaceutical-grade botanical therapeutics platform that cultivates, processes, and distributes regulated plant-derived medicines and standardised APIs, with medical cannabis (CBPMs) as its core product. It operates a vertically integrated seed-to-patient supply chain and clinical research program, serving patients through licensed distribution partners across the UK and Europe.

1 investor

Circa Biotech converts organic waste into resources such as sustainable aviation fuel (SAF), insect protein, and organic fertilizer using engineering-based processes. Founded in 2020, it focuses on waste management and circular-economy solutions.

1 investor

Circadian Health develops technology solutions that optimize human health and performance through understanding and applying circadian science, with expertise in light's impact on biological rhythms.

1 investor

Circadian OS develops precision therapies based on circadian rhythm and biological timing science, combining biomarker data, multimodal temporal data, and closed-loop hardware to run clinical trials and partner with pharmaceutical companies. The company operates a platform-based approach in biomedical research aimed at improving treatment outcomes.

1 investor

Circe Scientific provides DMPK (drug metabolism and pharmacokinetics) and PK/PD consulting for biotech, pharmaceutical, and venture capital clients working in drug discovery and development. It supports research projects across inhaled, dermal, and oral drug delivery routes.

1 investor

Circumvent is a pharmaceutical and biotech company that studies monogenic disorders to inform the development of treatments for complex diseases. It applies genomics and neurotechnology approaches to drug discovery.

1 investor

Cirius Therapeutics is a clinical-stage pharmaceutical company developing therapies for patients with chronic metabolic diseases driven by insulin resistance, including Type 2 Diabetes and obesity.

1 investor

Cirqle is developing a hormone-free, on-demand contraceptive that uses a molecule to reinforce the natural cervical mucus barrier and block sperm. The technology is in pre-clinical development and targets women seeking non-hormonal birth control options.

1 investor

MLM Medical Labs (which acquired CirQuest Labs) provides central and specialty laboratory services for global clinical trials, including clinical testing, biomarker assay development, clinical trial kit building, sample analysis, and biological sample storage. It serves biotech and pharmaceutical companies developing drugs, operating central labs in Germany and Memphis, Tennessee.

1 investor

CisPoly develops non-invasive early cancer screening and diagnostic tests based on DNA methylation, targeting three major gynecological cancers: cervical, endometrial, and ovarian cancer. Its products are aimed at women's health and clinical use, supported by prospective multicenter clinical trials and published research.

1 investor

Cisterna Biologics develops yeast-engineered mRNA manufacturing technology that can be selectively purified to drive protein expression in human cells. The company targets cost-effective, scalable, and non-immunogenic mRNA production for therapeutic applications.

1 investor

Citrus Health Group is a healthcare communications agency that provides scientific, clinical, and commercialization support to biopharmaceutical companies bringing new assets to market. It offers services including medical communications, commercialization strategy, market access, and launch planning across therapeutic areas such as oncology and rare diseases.

1 investor

Civetbio is a Chinese biotechnology company supporting research and development of live biotherapeutic products. Its offering combines a microbiota bank, a clinical intervention platform and a bioinformatics pipeline built on large datasets, giving researchers resources to study Asian gut microbiome profiles and how they differ by region.

1 investor

Clara Health operates a decentralized clinical trial platform that connects patients with clinical studies and provides 24/7 patient navigators to guide them through matching, scheduling, insurance, and paperwork at no cost. It also helps trial sponsors reach diverse and representative patient populations beyond physical trial sites; the company has been acquired by clinical research organization M&B Sciences Inc.

1 investor

ClaremontBio manufactures sample preparation devices and reagents for molecular diagnostics and genomic research, including cell lysis, DNA/RNA extraction, and detection systems. The company serves academic institutions, diagnostics labs, and life science research organizations globally.

1 investor

Clarion Healthcare is a consulting firm that provides commercialization strategy services to life sciences and pharmaceutical companies across therapeutic areas and the product life cycle. Its consultants advise on asset, portfolio, and corporate-level decisions to support drug development and commercial launch.

1 investor

Claris Ventures SGR is an Italy-based venture capital firm founded in 2019 that invests in early-stage biopharma companies emerging from the Italian life sciences research ecosystem. Through its Claris Biotech I fund, it backs new companies developing drugs targeting unmet patient needs.

1 investor

Clarity Pharmaceuticals is a clinical-stage radiopharmaceutical company developing targeted therapies and imaging products for cancer treatment in children and adults.

1 investor

Clarivate is a global provider of enriched data, insights, analytics, workflow solutions and expert services serving academia, government, intellectual property, and life sciences sectors. The company serves universities, pharma companies, biotech firms, medtech organizations, and R&D enterprises across 180+ countries.

1 investor

Claryx offers a fully managed genomic surveillance service for hospitals that sequences patient infections and environmental samples (air, sinks, surfaces, wastewater), matches them at the strain level to trace transmission, recommends responses, and confirms whether interventions worked. It is aimed at hospital Infection Prevention and Control teams and clinical leadership to reduce hospital-acquired infections.

1 investor

Clean Chemistry develops oxidation-based water treatment chemistries for microbial control, water clarification, recycling and disposal across industries including energy, pulp and paper, food and beverage, and cooling towers. Its products aim to reduce fresh water use, remove contaminants, and lower operating costs compared to traditional oxidizers.

1 investor